Año: 2022
Journal Impact Factor (JIF): 16,6
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| MULTIDISCIPLINARY SCIENCES | SCIE | 6/73 | Q1 | T1 | D1 |
Año: 2022
Journal Citation Indicator (JCI): 3,240
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| MULTIDISCIPLINARY SCIENCES | 7/134 | Q1 | T1 | D1 | 95,15 |
Año:
2022
CiteScore:
24,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 6/212 | Q1 | T1 | D1 |
| Chemistry (all) | 16/407 | Q1 | T1 | D1 |
| Physics and Astronomy (all) | 9/240 | Q1 | T1 | D1 |
SJR año:
2023
Factor de Impacto:
4,887
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 11/304 | Q1 | T1 | D1 |
| Chemistry (miscellaneous) | 14/495 | Q1 | T1 | D1 |
| Physics and Astronomy (miscellaneous) | 9/304 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Canada Research Chair in Adipocyte Development | 115881 |
| CIHR | 2009-1039 |
| CIHR Project Grant | - |
| Diabetes UK Project | PJT-153144 |
| EFPIA | - |
| European Union | - |
| Experimental Challenge Grant (DIVA) | BDA16/0005485 |
| Faculty of Medicine at Lund University | - |
| Icelandic Research Fund | 113102006 |
| Innovation Canada | - |
| Innovative Medicines Initiative 2 Joint Undertaking | - |
| MRC | MR/J0003042/1; MR/L020149/1; MR/L02036X/1 |
| Netherlands Organisation for Health Research and Development | 459001015; PJT-168853 |
| Swedish Foundation for Strategic Research | 102820/Z/13/Z |
| Swedish governmental funding of clinical research (ALF) | - |
| Swedish Research Council | 2020-02191; 2020-02191 |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | 184845-051 |
| Vinnova Swelife | 16.0097 |
| Wellcome Trust | 212625/Z/18/Z |
| Wellcome Trust Investigator Award | MR/R022259/1 |
| Wellcome Trust New Investigator Award | 212625/Z/18/Z |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Slieker, Roderick C. | Leiden University Medical Center - LUMC; Amsterdam Public Health (Netherlands) |
| 2 | Donnelly, Louise A. | University of Dundee School of Medicine (United Kingdom) |
| 3 | Akalestou, Elina | Imperial College London (United Kingdom) |
| 4 | Lopez-Noriega, Livia | Imperial College London (United Kingdom) |
| 5 | Melhem, Rana | Centre Hospitalier de L'Universite de Montreal (Canada) |
| 6 | Güneş, Ayşim | University of Montreal (Canada) |
| 7 | Abou Azar, Frederic | Centre Hospitalier de L'Universite de Montreal (Canada) |
| 8 | Efanov, Alexander | Eli Lilly and Company (United States) |
| 9 | Georgiadou, Eleni | Imperial College London (United Kingdom) |
| 10 | Muniangi-Muhitu, Hermine | Imperial College London (United Kingdom) |
| 11 | Sheikh, Mahsa | Imperial College London (United Kingdom) |
| 12 | Giordano, Giuseppe N. | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 13 | Åkerlund, Mikael | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 14 | Ahlqvist, Emma | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 15 | Ali, Ashfaq | Steno Diabetes Center Copenhagen (Denmark) |
| 16 | Banasik, Karina | Novo Nordisk Foundation Center for Protein Research (Denmark) |
| 17 | Brunak, Søren | Novo Nordisk Foundation Center for Protein Research (Denmark) |
| 18 | Barovic, Marko | Universitätsklinikum Carl Gustav Carus Dresden (Germany) |
| 19 | Bouland, Gerard A. | Leiden University Medical Center - LUMC (Netherlands) |
| 20 | Burdet, Frédéric | Swiss Institute of Bioinformatics (Switzerland) |
| 21 | Canouil, Mickaël | (Epi)génomique Fonctionnelle et Physiologie Moléculaire Du Diabète et Maladies Associées (France) |
| 22 | Dragan, Iulian | Swiss Institute of Bioinformatics (Switzerland) |
| 23 | Elders, Petra J.M. | Amsterdam Public Health (Netherlands) |
| 24 | Fernandez, Celine | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 25 | Festa, Andreas | Eli Lilly Regional Operations GmbH; LK Stockerau (Austria) |
| 26 | Fitipaldi, Hugo | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 27 | Froguel, Phillippe | Imperial College London; (Epi)génomique Fonctionnelle et Physiologie Moléculaire Du Diabète et Maladies Associées (United Kingdom) |
| 28 | Gudmundsdottir, Valborg | Icelandic Heart Association; Læknadeild Háskóla Íslands (Iceland) |
| 29 | Gudnason, Vilmundur | Icelandic Heart Association; Læknadeild Háskóla Íslands (Iceland) |
| 30 | Gerl, Mathias J. | Lipotype GmbH (Germany) |
| 31 | van der Heijden, Amber A. | Amsterdam Public Health (Netherlands) |
| 32 | Jennings, Lori L. | Novartis Institutes for BioMedical Research, Inc. (United States) |
| 33 | Hansen, Michael K. | Janssen Research & Development (Belgium) |
| 34 | Kim, Min | Faculty of Life Sciences & Medicine; Steno Diabetes Center Copenhagen (United Kingdom) |
| 35 | Leclerc, Isabelle | Imperial College London; Centre Hospitalier de L'Universite de Montreal (United Kingdom) |
| 36 | Klose, Christian | Lipotype GmbH (Germany) |
| 37 | Kuznetsov, Dmitry | Swiss Institute of Bioinformatics (Switzerland) |
| 38 | Mansour Aly, Dina | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 39 | Mehl, Florence | Swiss Institute of Bioinformatics (Switzerland) |
| 40 | Marek, Diana | Swiss Institute of Bioinformatics (Switzerland) |
| 41 | Melander, Olle | Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 42 | Niknejad, Anne | Swiss Institute of Bioinformatics (Switzerland) |
| 43 | Ottosson, Filip | Statens Serum Institut; Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 44 | Pavo, Imre | Eli Lilly Regional Operations GmbH (Austria) |
| 45 | Duffin, Kevin | Eli Lilly and Company (United States) |
| 46 | Syed, Samreen K. | Eli Lilly and Company (United States) |
| 47 | Shaw, Janice L. | Eli Lilly and Company (United States) |
| 48 | Cabrera, Over | Eli Lilly and Company (United States) |
| 49 | Pullen, Timothy J. | Imperial College London; King's College London (United Kingdom) |
| 50 | Simons, Kai | Lipotype GmbH (Germany) |
| 51 | Solimena, Michele | Universitätsklinikum Carl Gustav Carus Dresden (Germany) |
| 52 | Suvitaival, Tommi | Steno Diabetes Center Copenhagen (Denmark) |
| 53 | Wretlind, Asger | Steno Diabetes Center Copenhagen (Denmark) |
| 54 | Rossing, Peter | Københavns Universitet; Steno Diabetes Center Copenhagen (Denmark) |
| 55 | Lyssenko, Valeriya | Universitetet i Bergen; Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 56 | Legido Quigley, Cristina | Faculty of Life Sciences & Medicine; Steno Diabetes Center Copenhagen (United Kingdom) |
| 57 | Groop, Leif | Helsingin Yliopisto; Institutionen för Kliniska Vetenskaper, Malmö (Sweden) |
| 58 | Thorens, Bernard | Université de Lausanne (UNIL) (Switzerland) |
| 59 | Franks, Paul W. | Harvard T.H. Chan School of Public Health; Institutionen för Kliniska Vetenskaper, Malmö (United States) |
| 60 | Lim, Gareth E. | Centre Hospitalier de L'Universite de Montreal (Canada) |
| 61 | Estall, Jennifer | University of Montreal (Canada) |
| 62 | Ibberson, Mark | Swiss Institute of Bioinformatics (Switzerland) |
| 63 | Beulens, Joline W.J. | University Medical Center Utrecht; Amsterdam Public Health (Netherlands) |
| 64 | Leiden University Medical Center - LUMC; Amsterdam Public Health (Netherlands) | |
| 65 | University of Dundee School of Medicine (United Kingdom) | |
| 66 | Imperial College London; Centre Hospitalier de L'Universite de Montreal; Lee Kong Chian School of Medicine (United Kingdom) |
